// App-Quantinova.ai

: Single inhaler triple therapy in patients with advanced COPD: healthcare resource utilisation and cost data from the FULFIL study

Researchers

Presenter

  • Afisi Ismaila

Principal Investigators

  • Helen Barnacle

  • Ruby Birk

  • Noushin Brealey

  • Nancy Risebrough

  • Dhvani Shah

  • Maggie Tabberer

  • Shiyuan Zhang

  • Chang-Qing Zhu

  • David Lipson

Medical Centers

  • NIH/NIEHS, Research Triangle Park, United States of America

  • GSK, Uxbridge, United Kingdom

  • ICON Health Economics, Toronto, ON, Canada.

  • ICON Health Economics, New York, United States of America

  • GSK, Upper Providence, United States of America

  • CSL Behring, King of Prussia, United States of America

Locations

  • United States

  • United Kingdom

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

Disease

  • Chronic obstructive pulmonary disease

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved